Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v5-FR | Version v2-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2021-11-15 (Updated) | 2021-11-08 |
| Drug Identification Number | 02475448 | 02475448 |
| Brand name | SANDOZ SILODOSIN | SANDOZ SILODOSIN |
| Common or Proper name | SILODOSIN | SILODOSIN |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | SILODOSIN | SILODOSIN |
| Strength(s) | 8MG | 8MG |
| Dosage form(s) | CAPSULE | CAPSULE |
| Route of administration | ORAL | ORAL |
| Packaging size | 100HGC BO | 100HGC BO |
| Anatomical Therapeutical Chemical (ATC) code | G04CA | G04CA |
| Anatomical Therapeutical Chemical (ATC) description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | ||
| Actual start date | 2021-11-08 | 2021-11-08 |
| Estimated end date | 2021-11-26 | 2021-11-26 |
| Actual end date | 2021-11-15 (Updated) | |
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |